GENEVA, July 9 -- QUALITY PHARMA S.A.C. filed a patent application (PE2025/000002) for “MULTIPLEXED NUCLEIC ACID DETECTION PLATFORM BASED ON A CRISPR-CAS12 SYSTEM AND ELECTROCHEMICAL BIOSENSORS”. With publication no. WO/2026/147335, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: none
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....